drugset / Trial / NCT02243813

Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

NCT02243813

Phase 1 Completed 24 enrolled Johns Hopkins University
RandomizedParallel-groupOpen-labelBasic science

Summary

The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders.

Timeline

Start
2015-03
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 20 mg
Subject Psilocybin Other / unclassified 30 mg

Indications

No indication recorded.